Mechanism and current progress of Poly ADP-ribose polymerase (PARP) inhibitors in the treatment of ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mechanism and current progress of Poly ADP-ribose polymerase (PARP) inhibitors in the treatment of ovarian cancer

Published:2020-03 Issue: Volume:123 Page:109661
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Zheng Feiyue,Zhang Yi,Chen Shuang,Weng Xiang,Rao Yuefeng,Fang Hongmei

Funder

National and Zhejiang Provincial Nature Science Foundation of China

Zhejiang Provincial health science project

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference88 articles.

1. PARP inhibitors: synthetic lethality in the clinic;Lord;Science,2017

2. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int. J. Cancer,2015

3. Ovarian cancer;Matulonis;Nat. Rev. Dis. Primers,2016

4. Ovarian cancer statistics, 2018;Torre;CA Cancer J. Clin.,2018

5. Cancer Statistics, 2017;Siegel;CA Cancer J. Clin.,2017

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Poly (ADP-ribose) polymerase (PARP) inhibitors as anticancer agents: An outlook on clinical progress, synthetic strategies, biological activity, and structure-activity relationship;European Journal of Medicinal Chemistry;2024-08

2. First-line PARP inhibitor maintenance treatment in ovarian carcinoma for older adult women: a review of the current literature;Clinical and Translational Oncology;2024-07-19

3. PARP inhibitors in ovarian cancer therapy;Prospects in Pharmaceutical Sciences;2024-06-18

4. Effect of Polyamorphism on the Morphology, Dissolution, and Stability of Olaparib;Crystal Growth & Design;2024-06-10

5. Euonymus alatus and its compounds suppress hydrogen peroxide-induced oxidative stress in HT22 cells;Food Science and Biotechnology;2024-06-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3